Global Management, Ltd.Darw... Net Worth

Insiders trading at Ambrx Biopharma

Over the last 2 years, insiders at Ambrx Biopharma have traded over $616,598 worth of Ambrx Biopharma stock and bought 12,273,134 units worth $123,242,196 . The most active insiders traders include Asset Management, Lp Chen B..., Daniel J. O'connor e Paul V Maier. On average, Ambrx Biopharma executives and independent directors trade stock every 32 days with the average trade being worth of $49,343,700. The most recent stock trade was executed by Sonja Nelson on 27 October 2023, trading 12,778 units of AMAM stock currently worth $125,480.

What does Ambrx Biopharma do?

Ambrx Biopharma executives and stock owners

Ambrx Biopharma executives and other stock owners filed with the SEC include:

• Dr. Janice Lu M.D., Ph.D.,
  Chief Medical Officer
• Dr. Shawn Shao-Hui Zhang,
  Sr. VP of R&D Operations and Ambrx China
• Simon J. Allen B.Sc., M.B.A., MBA,
  Chief Bus. Officer
• Sonja Nelson CPA,
  Chief Financial Officer
• Dr. Feng Tian Ph.D.,
  Pres, Member of Scientific Advisory Board, CEO & Chairman
• Janet Loesberg,
  
• Xiaowei Chang,
  Director
• Global Management, Ltd. Darwin,
  10% owner
• Stephen C. Glover,
  
• Kate Hermans,
  
• Paul V Maier,
  
• Sonja Nelson,
  Chief Financial Officer
• Katrin Rupalla,
  Director
• Asset Management, Lp Chen B...,
  
• Global Management, Ltd.Darw...,
  
• Daniel J. O'connor,
  President and CEO
• Andrew Aromando,
  Chief Operating Officer